Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Prepaid Assets (2017 - 2025)

Historic Prepaid Assets for Autolus Therapeutics (AUTL) over the last 9 years, with Q3 2025 value amounting to $85.3 million.

  • Autolus Therapeutics' Prepaid Assets rose 4324.15% to $85.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $85.3 million, marking a year-over-year increase of 4324.15%. This contributed to the annual value of $67.3 million for FY2024, which is 9254.73% up from last year.
  • Latest data reveals that Autolus Therapeutics reported Prepaid Assets of $85.3 million as of Q3 2025, which was up 4324.15% from $67.9 million recorded in Q2 2025.
  • Autolus Therapeutics' 5-year Prepaid Assets high stood at $85.3 million for Q3 2025, and its period low was -$22.7 million during Q3 2021.
  • Moreover, its 5-year median value for Prepaid Assets was $48.3 million (2021), whereas its average is $42.7 million.
  • Within the past 5 years, the most significant YoY rise in Autolus Therapeutics' Prepaid Assets was 416930.86% (2021), while the steepest drop was 130827.18% (2021).
  • Autolus Therapeutics' Prepaid Assets (Quarter) stood at $36.3 million in 2021, then grew by 18.56% to $43.0 million in 2022, then fell by 18.7% to $35.0 million in 2023, then skyrocketed by 92.55% to $67.3 million in 2024, then grew by 26.75% to $85.3 million in 2025.
  • Its last three reported values are $85.3 million in Q3 2025, $67.9 million for Q2 2025, and $68.8 million during Q1 2025.